RATIOS
Sun Pharma Advanced Research Company Ltd.
BSE
Jun 05, 04:01
162.05
+5.00 (+ 3.18%)
Volume
727622
Prev. Close
157.05
Open Price
156.75
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 05, 03:58
162.04
+5.21 (+ 3.32%)
Volume
6549366
Prev. Close
156.83
Open Price
156.83
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
162.04 (16427)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE232I01014
|
Market Cap. ( ₹ in Cr. )
|
5258.55
|
P/BV
|
-67.96
|
Book Value ( ₹ )
|
-2.38
|
|
BSE Code
|
532872
|
52 Week High/Low ( ₹ )
|
258/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
NSE Code
|
SPARCEQ
|
Book Closure
|
30/09/2020
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -10.64 | -11.96 | -7.82 | -7.73 | -5.77 |
| Diluted EPS (Rs.) | -10.64 | -11.96 | -7.82 | 7.73 | -5.77 |
| Cash EPS (Rs.) | -10.30 | -11.59 | -6.50 | -7.11 | -5.35 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.80 | 3.85 | 15.80 | 1.15 | -6.42 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.80 | 3.85 | 15.80 | 1.15 | -6.42 |
| Revenue From Operations / Share (Rs.) | 2.21 | 2.33 | 7.36 | 5.05 | 9.65 |
| PBDIT / Share (Rs.) | -10.03 | -11.53 | -6.26 | -6.62 | -4.94 |
| PBIT / Share (Rs.) | -10.36 | -11.91 | -6.62 | -6.99 | -5.36 |
| PBT / Share (Rs.) | -10.64 | -11.96 | -6.86 | -7.48 | -5.77 |
| Net Profit / Share (Rs.) | -10.64 | -11.96 | -6.86 | -7.48 | -5.77 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -453.50 | -495.49 | -85.09 | -131.07 | -51.22 |
| PBIT Margin (%) | -468.59 | -511.54 | -90.01 | -138.48 | -55.53 |
| PBT Margin (%) | -481.00 | -513.73 | -93.21 | -148.19 | -59.74 |
| Net Profit Margin (%) | -481.00 | -513.73 | -93.21 | -148.19 | -59.74 |
| Return on Networth / Equity (%) | 0.00 | -310.83 | -43.40 | -651.37 | 0.00 |
| Return on Capital Employeed (%) | 756.77 | -159.39 | -33.00 | -174.92 | 3836.49 |
| Return On Assets (%) | -104.83 | -79.80 | -26.81 | -72.61 | -65.80 |
| Long Term Debt / Equity (X) | -0.45 | 0.00 | 0.00 | 0.00 | -0.69 |
| Total Debt / Equity (X) | -1.17 | 0.37 | 0.00 | 2.40 | -1.17 |
| Asset Turnover Ratio (%) | 0.17 | 0.11 | 0.43 | 0.53 | 1.01 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.06 | 1.01 | 2.54 | 0.41 | 0.27 |
| Quick Ratio (X) | 0.06 | 1.01 | 2.54 | 0.41 | 0.27 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -36.53 | -226.15 | -26.61 | -13.50 | -12.17 |
| Interest Coverage Ratio (Post Tax) (%) | -37.75 | -233.48 | -28.15 | -14.26 | -13.19 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 5059.60 | 11897.92 | 5712.17 | 8144.74 | 3900.74 |
| EV / Net Operating Revenue (X) | 70.50 | 157.49 | 23.92 | 59.34 | 15.42 |
| EV / EBITDA (X) | -15.55 | -31.79 | -28.11 | -45.27 | -30.11 |
| MarketCap / Net Operating Revenue (X) | 66.92 | 158.92 | 24.39 | 58.81 | 14.68 |
| Price / BV (X) | -21.77 | 96.16 | 11.36 | 258.49 | -22.07 |
| Price / Net Operating Revenue (X) | 66.92 | 158.93 | 24.39 | 58.81 | 14.68 |
| EarningsYield | -0.07 | -0.03 | -0.03 | -0.02 | -0.04 |